Imunon Inc Stock Performance
| IMNN Stock | USD 3.25 0.02 0.61% |
The company retains a Market Volatility (i.e., Beta) of 0.38, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Imunon's returns are expected to increase less than the market. However, during the bear market, the loss of holding Imunon is expected to be smaller as well. At this point, Imunon Inc has a negative expected return of -0.29%. Please make sure to check out Imunon's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if Imunon Inc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Imunon Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Actual Historical Performance (%)
One Day Return (0.61) | Five Day Return (3.56) | Year To Date Return (17.72) | Ten Year Return (99.91) | All Time Return (100.00) |
Last Split Factor 115:100 | Last Split Date 2025-08-07 |
1 | Is Imunon Inc. stock a top hedge fund pick - July 2025 News Drivers Safe Swing Trade Setup Alerts - newser.com | 11/21/2025 |
2 | Aug Patterns Can Imunon Inc CBO stock sustain institutional flows - Earnings Risk Report Low Risk High Reward Trade Ideas - moha.gov.vn | 12/24/2025 |
3 | Imunon Signs Securities Purchase Agreement With Undisclosed Healthcare-Focused Institutional Investor - TradingView Track All Markets | 12/31/2025 |
4 | Acquisition by Stacy Lindborg of 56187 shares of Imunon at 3.95 subject to Rule 16b-3 | 01/02/2026 |
5 | Market Trends Can Imunon Inc stock deliver surprise earnings beat - Weekly Risk Report Daily Risk Controlled Trade Plans - moha.gov.vn | 01/06/2026 |
6 | IPO Launch Why Imunon Inc stock is recommended by analysts - July 2025 Volume AI Driven Stock Price Forecasts - moha.gov.vn | 01/13/2026 |
7 | Insider Trading | 01/15/2026 |
8 | Stock Analysis Can Imunon Inc sustain earnings growth - Trade Ideas Pattern Based Trade Signal System - baoquankhu1.vn | 01/28/2026 |
| Begin Period Cash Flow | 5.8 M | |
| Total Cashflows From Investing Activities | 9.8 M |
Imunon Relative Risk vs. Return Landscape
If you would invest 409.00 in Imunon Inc on November 18, 2025 and sell it today you would lose (84.00) from holding Imunon Inc or give up 20.54% of portfolio value over 90 days. Imunon Inc is currently does not generate positive expected returns and assumes 4.0637% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Imunon, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Imunon Target Price Odds to finish over Current Price
The tendency of Imunon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.25 | 90 days | 3.25 | more than 93.0 |
Based on a normal probability distribution, the odds of Imunon to move above the current price in 90 days from now is more than 93.0 (This Imunon Inc probability density function shows the probability of Imunon Stock to fall within a particular range of prices over 90 days) .
Imunon Price Density |
| Price |
Predictive Modules for Imunon
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Imunon Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Imunon Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Imunon is not an exception. The market had few large corrections towards the Imunon's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Imunon Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Imunon within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.17 | |
β | Beta against Dow Jones | 0.38 | |
σ | Overall volatility | 0.30 | |
Ir | Information ratio | -0.05 |
Imunon Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Imunon for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Imunon Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Imunon Inc generated a negative expected return over the last 90 days | |
| Imunon Inc has high historical volatility and very poor performance | |
| Imunon Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (18.62 M) with profit before overhead, payroll, taxes, and interest of 2.72 M. | |
| Imunon Inc currently holds about 42.11 M in cash with (18.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Imunon Inc has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Stock Analysis Can Imunon Inc sustain earnings growth - Trade Ideas Pattern Based Trade Signal System - baoquankhu1.vn |
Imunon Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Imunon Stock often depends not only on the future outlook of the current and potential Imunon's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Imunon's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 882.3 K | |
| Cash And Short Term Investments | 5.9 M |
Imunon Fundamentals Growth
Imunon Stock prices reflect investors' perceptions of the future prospects and financial health of Imunon, and Imunon fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Imunon Stock performance.
| Return On Equity | -2.33 | ||||
| Return On Asset | -0.78 | ||||
| Current Valuation | 6.9 M | ||||
| Shares Outstanding | 3.4 M | ||||
| Price To Book | 2.71 X | ||||
| Price To Sales | 17.94 X | ||||
| Gross Profit | 2.72 M | ||||
| EBITDA | (17.9 M) | ||||
| Net Income | (18.62 M) | ||||
| Cash And Equivalents | 42.11 M | ||||
| Cash Per Share | 5.93 X | ||||
| Total Debt | 1.14 M | ||||
| Debt To Equity | 0.14 % | ||||
| Current Ratio | 6.52 X | ||||
| Book Value Per Share | 1.41 X | ||||
| Cash Flow From Operations | (18.85 M) | ||||
| Earnings Per Share | (12.53) X | ||||
| Market Capitalization | 11.05 M | ||||
| Total Asset | 9.72 M | ||||
| Retained Earnings | (406.8 M) | ||||
| Working Capital | 3.22 M | ||||
About Imunon Performance
By examining Imunon's fundamental ratios, stakeholders can obtain critical insights into Imunon's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Imunon is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 178.15 | 169.25 | |
| Return On Tangible Assets | (1.72) | (1.81) | |
| Return On Capital Employed | (4.46) | (4.24) | |
| Return On Assets | (1.72) | (1.81) | |
| Return On Equity | (5.05) | (4.79) |
Things to note about Imunon Inc performance evaluation
Checking the ongoing alerts about Imunon for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Imunon Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Imunon Inc generated a negative expected return over the last 90 days | |
| Imunon Inc has high historical volatility and very poor performance | |
| Imunon Inc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (18.62 M) with profit before overhead, payroll, taxes, and interest of 2.72 M. | |
| Imunon Inc currently holds about 42.11 M in cash with (18.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Imunon Inc has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Stock Analysis Can Imunon Inc sustain earnings growth - Trade Ideas Pattern Based Trade Signal System - baoquankhu1.vn |
- Analyzing Imunon's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Imunon's stock is overvalued or undervalued compared to its peers.
- Examining Imunon's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Imunon's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Imunon's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Imunon's stock. These opinions can provide insight into Imunon's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imunon Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Biotechnology sector continue expanding? Could Imunon diversify its offerings? Factors like these will boost the valuation of Imunon. Market participants price Imunon higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Imunon data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Imunon Inc requires distinguishing between market price and book value, where the latter reflects Imunon's accounting equity. The concept of intrinsic value - what Imunon's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Imunon's price substantially above or below its fundamental value.
Please note, there is a significant difference between Imunon's value and its price as these two are different measures arrived at by different means. Investors typically determine if Imunon is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Imunon's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.